India, Oct. 14 -- The National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, has partnered with AstraZeneca India to strengthen clinical research capabilities across 25 emerging research locations in the country, with a focus on developing skilled professionals and preparing clinical trial sites to meet inspection and operational requirements.
The memorandum of understanding (MoU) was signed in New Delhi in the presence of Manoj Joshi, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers. The initiative aligns with the government's Biopharma SHAKTI programme, which aims to strengthen India's biopharmaceutical ecosystem, including the establishment of 1,000 clinical trial sites nationwide....